Evidence map›Paper›PMID 39836271›Full record

ArticleRheumatology international2025

Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review.

Marta Jaskólska, Magdalena Rytlewska, Natalia Aleksandra Dułak, Miłosz Ulanowski, Mariusz Kwarciany, Mariusz Stanisław Wiglusz, Wiesław Jerzy Cubała, Michał Chmielewski

Abstract readCase Reports
In one paragraph

Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta Jaskólska *Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0002-1408-4490
Magdalena Rytlewska *Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Gdansk, Poland. magdalena.rytlewska@gmail.com.ORCID 0009-0000-0860-3998
Natalia Aleksandra DułakDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0002-1119-6227
Miłosz UlanowskiDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.ORCID 0009-0009-6463-4196
Mariusz KwarcianyDepartment of Adult Neurology, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0001-6776-1937
Mariusz Stanisław WigluszDepartment of Psychiatry, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0001-5183-5954
Wiesław Jerzy CubałaDepartment of Psychiatry, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0001-6343-8454
Michał ChmielewskiDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0001-8126-8786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sjogren's disease (SjD) is a chronic and disabling autoimmune disease, predominantly characterized by dryness of the mouth and eyes, resulting from lymphocytic infiltration of exocrine glands. While these are the most prominent symptoms, extra-glandular manifestations are also common. Studies suggest that up to 70% of SjD patients experience neurological symptoms, which interestingly often precede the hallmark dryness. Although every structure of the nervous system can be affected, disorders of peripheral nervous system (PNS) are more common than central nervous system (CNS) involvement. The CNS manifestations can range from subtle to severe, with some patients experiencing a rapid progression of symptoms. The literature documents cases where patients initially diagnosed with Creutzfeldt-Jakob disease, neurosarcoidosis, temporary hemiplegia, neuromyelitis optica, or epilepsy were ultimately diagnosed as having SjD. Here, we present five SjD patient cases, each with a different manifestation of CNS involvement, along with an overview of the current understanding of CNS disorders in the course of the disease. In four cases, the neurological manifestations appeared before the onset of sicca symptoms. In one patient, diagnosis was delayed by 15 years due to an atypical presentation. After receiving immunosuppression, all patients experienced notable alleviation of their symptoms.

Indexed as

Central Nervous System DiseasesSjogren's SyndromeHumansImmunosuppressive AgentsTreatment OutcomeImmunosuppressive AgentsAntinuclear antibodiesCentral nervous systemNervous system diseasesNeurologic manifestationsSjögren’s diseaseSjögren’s syndrome

Identifiers

PMID39836271
PMCPMC11750892

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.